This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Supporters say Health and Human Services Secretary Robert F. Kennedy, Jr. is fulfilling his vision…
Originally broadcast Wednesday, August 27 Dr. Victor Montori, a Mayo Clinic endocrinologist, internationally recognized researcher,…
Dr. Kenneth Cooper’s FitnessGram is on the ropes. President Trump recently reestablished the Presidential Fitness…
Originally broadcast August 14, 2025 One in five U.S. adults lives with a mental illness,…
Originally broadcast August 7, 2025 Experts who believe in the “food is medicine” concept say…
Americans are living longer for many reasons and experts credit Medicare and Medicaid for some…